Leaderboards/Hormonal and reproductive studies

Hormonal and reproductive studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Josefine Windfeld‐Mathiasen
Frederiksberg Hospital
2
Jaleh Fallah
United States Food and Drug Administration
3
Runchun Huang
First Hospital of Lanzhou University
4
Mariana Lenharo
Institute of Nature Management
5
Visesh Vignesh
University of Bath
6
Morgan Scarth
Oslo University Hospital
7
Yutao Lou
Zhejiang Provincial People's Hospital
8
Tobias Langer
University Centre of Legal Medicine
9
Ryan D. Paulukinas
Translational Therapeutics (United States)
10
Léa G Deltourbe
Centre National de la Recherche Scientifique

Papers

1
Diabetes-induced male infertility: potential mechanisms and treatment options
Molecular Medicine|2024
90 cit.
2
Advancements in Cortisol Detection: From Conventional Methods to Next-Generation Technologies for Enhanced Hormone Monitoring
ACS Sensors|2024
82 cit.
3
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis
Journal of Clinical Oncology|2024
74 cit.
4
The mechanism of action of <i>Botrychium (Thunb.) Sw.</i> for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics
Journal of Pharmacy and Pharmacology|2024
49 cit.
5
Cardiovascular Disease in Anabolic Androgenic Steroid Users
Circulation|2025
47 cit.
6
Mortality Among Users of Anabolic Steroids
JAMA|2024
39 cit.
7
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma
Clinical Cancer Research|2024
27 cit.
8
Publication in Drug Testing and Analysis (2024) [12 citations, W4390743688]
Drug Testing and Analysis|2024
12 cit.
9
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysis
JNCI Journal of the National Cancer Institute|2024
12 cit.
10
Publication in Drug Testing and Analysis (2025) [11 citations, W4408957204]
Drug Testing and Analysis|2025
11 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Astrid Bjørnebekk
Oslo University Hospital
2
Karl‐Heinz Storbeck
Stellenbosch University
3
Eva Estébanez‐Perpiñá
Institute for Biomedicine
4
Pierre‐Yves Garnier
Scientific Centre of Monaco
5
Muhammet Sevindik
Ordu University
6
Görkem Karakaş Uğurlu
Ankara Mevki Asker Hastanesi
7
Korkut Budak
Istanbul University
8
Zhenfei Li
Tianjin University
9
Michael Berkwits
Centers for Disease Control and Prevention
10
Daniele Caprioli
Fondazione Santa Lucia

Papers

1
Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway
Drug and Alcohol Dependence|2022
36 cit.
2
Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer
Cell Reports Medicine|2022
30 cit.
3
The multivalency of the glucocorticoid receptor ligand-binding domain explains its manifold physiological activities
Nucleic Acids Research|2022
29 cit.
4
Psychopathology among anabolic-androgenic steroid using and non-using female athletes in Norway
Journal of Psychiatric Research|2022
28 cit.
5
Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer
Journal of Clinical Investigation|2023
28 cit.
6
Management of prostate cancer by targeting 3βHSD1 after enzalutamide and abiraterone treatment
Cell Reports Medicine|2022
22 cit.
7
Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters
BMC Psychiatry|2023
22 cit.
8
Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study
Substance Abuse Treatment Prevention and Policy|2023
20 cit.
9
A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance
Science Advances|2023
19 cit.
10
Clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters
Brain and Behavior|2023
18 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Eberhard Nieschlag
University Hospital Münster
2
Shalender Bhasin
Brigham and Women's Hospital
3
Chawnshang Chang
China Medical University
4
Charles L. Sawyers
Memorial Sloan Kettering Cancer Center
5
Elizabeth M. Wilson
University of North Carolina at Chapel Hill
6
David J. Handelsman
Anzac Research Institute
7
Mario Maggi
University of Florence
8
David W. Russell
Pfizer (United States)
9
Walter L. Miller
University of California, San Francisco
10
Ronald S. Swerdloff
University of California, Los Angeles

Papers

1
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
New England Journal of Medicine|2001
5.2k cit.
2
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Science|2009
2.3k cit.
3
Molecular determinants of resistance to antiandrogen therapy
Nature Medicine|2003
2.3k cit.
4
Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Science|2004
1.8k cit.
5
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
New England Journal of Medicine|2006
1.8k cit.
6
The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men
New England Journal of Medicine|1996
1.7k cit.
7
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
The Journal of Clinical Endocrinology & Metabolism|2018
1.6k cit.
8
Adverse Events Associated with Testosterone Administration
New England Journal of Medicine|2010
1.5k cit.
9
Genomic correlates of clinical outcome in advanced prostate cancer
Proceedings of the National Academy of Sciences|2019
1.4k cit.
10
The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
Cell|1984
1.4k cit.

Reagents for Hormonal and reproductive studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

Vimentin (D21H3) Rabbit Monoclonal Antibody (APC Conjugate)

Cited in 5 papers
#95159$465
View Evidence →
Beckman Coulter

INHIBIN B GEN II ELISA kit

#A81303
View Evidence →
Cell Signaling TechnologyEvidence 64

ATP1B3 (F4Z2D) Rabbit Monoclonal Antibody

#10784$161,376
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

BARX1 (F2K3K) Rabbit Monoclonal Antibody

Cited in 9 papers
#42301$175,376
View Evidence →
Cell Signaling TechnologyEvidence 68

Phospho-TBK1/NAK (Ser172) (D52C2) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 5 papers
#14586$493
View Evidence →
Cell Signaling TechnologyEvidence 67

CD45 (Intracellular Domain) (D9M8I) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 5 papers
#14579$465
View Evidence →